Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
HCA Healthcare Analyst Ratings and Price Targets | NYSE:HCA | Benzinga
HCA Healthcare Inc has a consensus price target of $353.07 based on the ratings of 29 analysts. The high is $440 issued by TD Cowen on October 28, 2024. The low is $265 issued by JP Morgan on November 17, 2023. The 3 most-recent analyst ratings were released by RBC Capital, B of A Securities, and Cantor Fitzgerald on January 27, 2025, respectively. With an average price target of $386.33 between RBC Capital, B of A Securities, and Cantor Fitzgerald, there's an implied 14.89% upside for HCA Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
B of A Securities
Cantor Fitzgerald
Barclays
Keybanc
1calculated from analyst ratings
Analyst Ratings for HCA Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 01/27/2025 | Buy Now | 14.2% | RBC Capital | Ben Hendrix60% | $405 → $384 | Maintains | Outperform | Get Alert |
| 01/27/2025 | Buy Now | 10.04% | B of A Securities | Kevin Fischbeck67% | $380 → $370 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | 20.45% | Cantor Fitzgerald | Sarah James51% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 01/27/2025 | Buy Now | 8.85% | Barclays | Andrew Mok54% | $392 → $366 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 10.04% | Keybanc | Tim Rezvan47% | $420 → $370 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | 15.99% | Truist Securities | David Macdonald67% | $430 → $390 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 5.58% | Morgan Stanley | Craig Hettenbach58% | $406 → $355 | Maintains | Equal-Weight | Get Alert |
| 12/17/2024 | Buy Now | 13.01% | JP Morgan | Benjamin Rossi12% | → $380 | Assumes | → Neutral | Get Alert |
| 11/25/2024 | Buy Now | -4.83% | Wells Fargo | Stephen Baxter54% | $400 → $320 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/22/2024 | Buy Now | — | Raymond James | John Ransom75% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | 16.58% | Barclays | Andrew Mok54% | $396 → $392 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 18.96% | Wells Fargo | Stephen Baxter54% | $395 → $400 | Maintains | Equal-Weight | Get Alert |
| 10/28/2024 | Buy Now | 30.86% | TD Cowen | Gary Taylor59% | $450 → $440 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | 24.91% | Keybanc | Matthew Gillmor63% | $475 → $420 | Maintains | Overweight | Get Alert |
| 10/28/2024 | Buy Now | 18.96% | Oppenheimer | Michael Wiederhorn61% | $390 → $400 | Maintains | Outperform | Get Alert |
| 10/22/2024 | Buy Now | 17.47% | Wells Fargo | Stephen Baxter54% | $365 → $395 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | Buy Now | 41.26% | Keybanc | Matthew Gillmor63% | → $475 | Initiates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | 16.58% | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 10/01/2024 | Buy Now | 16.58% | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 09/03/2024 | Buy Now | 26.99% | Morgan Stanley | Craig Hettenbach58% | → $427 | Initiates | → Equal-Weight | Get Alert |
| 08/23/2024 | Buy Now | 20.45% | RBC Capital | Ben Hendrix60% | $378 → $405 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | 16.58% | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 16.58% | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 27.88% | Truist Securities | David Macdonald67% | $390 → $430 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 30.26% | UBS | Andrew Mok54% | $405 → $438 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | 8.55% | Wells Fargo | Stephen Baxter54% | $315 → $365 | Maintains | Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | 16.58% | Cantor Fitzgerald | Sarah James51% | $335 → $392 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2024 | Buy Now | 12.42% | RBC Capital | Ben Hendrix60% | $329 → $378 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 17.77% | Barclays | Andrew Mok54% | $376 → $396 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | 17.77% | Leerink Partners | — | $367 → $396 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 15.99% | Oppenheimer | Michael Wiederhorn61% | $345 → $390 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 15.99% | Truist Securities | David Macdonald67% | $375 → $390 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 11.82% | Barclays | Andrew Mok54% | $367 → $376 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | 11.52% | Deutsche Bank | Pito Chickering66% | $359 → $375 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | -1.26% | JP Morgan | Lisa Gill59% | $327 → $332 | Maintains | Neutral | Get Alert |
| 05/30/2024 | Buy Now | 17.77% | Baird | Michael Ha47% | → $396 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | 7.06% | TD Cowen | Gary Taylor59% | $371 → $360 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 9.14% | Barclays | Andrew Mok54% | $356 → $367 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | -2.16% | RBC Capital | Ben Hendrix60% | $322 → $329 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | 2.6% | Oppenheimer | Michael Wiederhorn61% | $330 → $345 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | 6.77% | Deutsche Bank | Pito Chickering66% | $330 → $359 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | -6.32% | Wells Fargo | Stephen Baxter54% | $303 → $315 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 5.87% | Barclays | Andrew Mok54% | → $356 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | -0.37% | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 01/31/2024 | Buy Now | -1.86% | Raymond James | John Ransom75% | $300 → $330 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | -4.24% | RBC Capital | Ben Hendrix60% | $308 → $322 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | 2.6% | Truist Securities | David Macdonald67% | $320 → $345 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | -10.78% | Raymond James | John Ransom75% | $280 → $300 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | -6.32% | Cantor Fitzgerald | Sarah James51% | $315 → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | Buy Now | -6.32% | Oppenheimer | Michael Wiederhorn61% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | -10.48% | Bernstein | Lance Wilkes61% | → $301 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | Buy Now | -21.19% | JP Morgan | Samik Chatterjee69% | $313 → $265 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | -16.73% | Stephens & Co. | Scott Fidel68% | → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2023 | Buy Now | -16.43% | Goldman Sachs | Jamie Perse60% | $329 → $281 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -24.46% | Wells Fargo | Stephen Baxter54% | $267 → $254 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | -10.78% | Truist Securities | David Macdonald67% | $340 → $300 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | -18.22% | Mizuho | Ann Hynes86% | $325 → $275 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | -15.54% | RBC Capital | Ben Hendrix60% | $315 → $284 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -16.73% | Stephens & Co. | Scott Fidel68% | $300 → $280 | Maintains | Overweight | Get Alert |
| 10/25/2023 | Buy Now | -17.03% | Citigroup | Jason Cassorla50% | $324 → $279 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | -16.73% | Raymond James | John Ransom75% | $320 → $280 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -20.59% | Wells Fargo | Stephen Baxter54% | $275 → $267 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | -6.32% | Cantor Fitzgerald | Sarah James51% | → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | Buy Now | -6.32% | RBC Capital | Ben Hendrix60% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | Buy Now | -6.02% | Credit Suisse | A.J. Rice68% | $311 → $316 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | -6.32% | Oppenheimer | Michael Wiederhorn61% | $310 → $315 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -3.35% | Mizuho | Ann Hynes86% | $305 → $325 | Maintains | Buy | Get Alert |
| 06/28/2023 | Buy Now | -10.78% | Barclays | Steve Valiquette53% | $275 → $300 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | 1.12% | Truist Securities | David Macdonald67% | $325 → $340 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | -9.29% | Mizuho | Ann Hynes86% | $298 → $305 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | -7.81% | Argus Research | David Toung72% | $285 → $310 | Maintains | Buy | Get Alert |
| 04/25/2023 | Buy Now | -18.22% | Wells Fargo | Stephen Baxter54% | $243 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | Buy Now | 2.6% | Bernstein | Lance Wilkes61% | $310 → $345 | Maintains | Outperform | Get Alert |
| 04/25/2023 | Buy Now | -18.22% | Barclays | Steve Valiquette53% | $256 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/24/2023 | Buy Now | -3.35% | Truist Securities | David Macdonald67% | $310 → $325 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | 4.09% | Jefferies | Brian Tanquilut45% | $325 → $350 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -7.81% | Deutsche Bank | Pito Chickering66% | $280 → $310 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -4.83% | Loop Capital | Joseph France65% | $285 → $320 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -3.05% | TD Cowen | Gary Taylor59% | $292 → $326 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | -3.94% | B of A Securities | Kevin Fischbeck67% | $294 → $323 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -4.83% | Raymond James | John Ransom75% | $300 → $320 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | -6.32% | RBC Capital | Ben Hendrix60% | $283 → $315 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | -7.51% | Credit Suisse | A.J. Rice68% | $282 → $311 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | -7.81% | Oppenheimer | Michael Wiederhorn61% | $270 → $310 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | -3.64% | Citigroup | Jason Cassorla50% | $293 → $324 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | -15.84% | Stephens & Co. | Scott Fidel68% | → $283 | Reiterates | → Overweight | Get Alert |
| 04/21/2023 | Buy Now | -9.59% | Cantor Fitzgerald | Sarah James51% | → $304 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | Buy Now | -15.84% | JP Morgan | Samik Chatterjee69% | $257 → $283 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | -11.38% | Mizuho | Ann Hynes86% | $279 → $298 | Maintains | Buy | Get Alert |
| 03/16/2023 | Buy Now | -15.84% | RBC Capital | Ben Hendrix60% | → $283 | Reiterates | → Outperform | Get Alert |
| 03/13/2023 | Buy Now | -15.84% | Stephens & Co. | Scott Fidel68% | → $283 | Reiterates | → Overweight | Get Alert |
| 02/23/2023 | Buy Now | -23.57% | JP Morgan | Lisa Gill59% | $235 → $257 | Maintains | Overweight | Get Alert |
| 02/22/2023 | Buy Now | -15.84% | Stephens & Co. | Scott Fidel68% | $275 → $283 | Maintains | Overweight | Get Alert |
| 02/13/2023 | Buy Now | -15.24% | Argus Research | David Toung72% | $260 → $285 | Maintains | Buy | Get Alert |
FAQ
What is the target price for HCA Healthcare (HCA) stock?
The latest price target for HCA Healthcare (NYSE:HCA) was reported by RBC Capital on January 27, 2025. The analyst firm set a price target for $384.00 expecting HCA to rise to within 12 months (a possible 14.20% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCA Healthcare (HCA)?
The latest analyst rating for HCA Healthcare (NYSE:HCA) was provided by RBC Capital, and HCA Healthcare maintained their outperform rating.
When was the last upgrade for HCA Healthcare (HCA)?
There is no last upgrade for HCA Healthcare
When was the last downgrade for HCA Healthcare (HCA)?
The last downgrade for HCA Healthcare Inc happened on November 25, 2024 when Wells Fargo changed their price target from $400 to $320 for HCA Healthcare Inc.
When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.
Is the Analyst Rating HCA Healthcare (HCA) correct?
While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a maintained with a price target of $405.00 to $384.00. The current price HCA Healthcare (HCA) is trading at is $336.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.